Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria

NCT00004940 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT00004940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 3
Overall status
Completed
Start date
May 31, 1996
Completion date
September 30, 2001
Enrollment
50
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

erythropoietic protoporphyria